Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria

Rationale: In the absence of a surgical lung biopsy, patients diagnosed with idiopathic pulmonary fibrosis (IPF) in clinical practice could participate in the INPULSIS trials of nintedanib if they had honeycombing and/or traction bronchiectasis plus reticulation, without atypical features of usual i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Respir Crit Care Med
Päätekijät: Raghu, Ganesh, Wells, Athol U., Nicholson, Andrew G., Richeldi, Luca, Flaherty, Kevin R., Le Maulf, Florence, Stowasser, Susanne, Schlenker-Herceg, Rozsa, Hansell, David M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Thoracic Society 2017
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5214917/
https://ncbi.nlm.nih.gov/pubmed/27331880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201602-0402OC
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia